Completed PHASE1 INTERVENTIONAL NCT00446771

A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects

Sponsor: Syntara

Interventions Mannitol

Updated 5 times since 2017 Last updated: Mar 12, 2007 Started: Oct 31, 2006 Completion: Nov 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00446771, this PHASE1 trial focuses on Healthy Volunteers and remains completed. Sponsored by Syntara, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Mar 2024 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Mar 2024 [monthly]

Completed PHASE1
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Syntara

Data source: Syntara

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.